A splice variant of uPAR, uPAR-del4/5, which is unable to bind uPA, is a known prognostic marker for breast cancer [94,96,113] although phenotypically, in vitro, cells overexpressing this variant appear to have reduced invasive properties [95,117], much like that observed for Rab31 [112]. This evidence concerns the gene PLAUR and breast cancer.